Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025. Total revenues comprise product sales and royalty, contract and other revenues. While ...

NORTHAMPTON, MA / ACCESS Newswire / November 4, 2025 / Public policies are central factors in determining healthcare interventions and access to medicines and treatment. Viatris leverages our global ...

Highlights of this morning’s presidential press conference include: The Mexican government presented the Michoacán Plan for Peace and Justice, which is organized around three main pillars. President ...

With a focus on Massachusetts, Rhode Island and Vermont, a project funded by the National Institute on Drug Abuse will analyze trends in drug use and barriers to care with the goal of strengthening ...

GSK PLC (GSK) reports robust sales growth and upgrades its full-year guidance, driven by strong performance in specialty medicines and oncology.

In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...

Gilead Sciences, Inc. announced today that its executives will be speaking at the following investor conferences: UBS Global Healthcare Conference on Monday, November 10 at 11:00 AM Eastern Time ...

Key findings from the survey demonstrate that 35.2 per cent of Kenyan organisations have achieved widespread or advanced AI ...

Kenya has inaugurated the new Consulate General in Jeddah, Saudi Arabia. The Consulate General, inaugurated by Foreign Affairs PS Korir Sing’oei on Monday, will serve as Kenya’s second diplomatic ...

Far too little aid is reaching Gaza nearly four weeks after a ceasefire, humanitarian agencies said on Tuesday, as hunger persists with winter approaching and old tents start to fray following ...